uk.investing.com on MSN24m
Evotec shares surge 20% on Halozyme's 2 billion euro takeover bid
Halozyme Therapeutics (NASDAQ:HALO) announced on Thursday its plans to acquire German drug developer Evotec SE ADR (NASDAQ:EVO) in a deal valued at approximately 2 billion euros ($2.10 billion), to ...
OMRON receives FDA authorisation for blood pressure monitors with AFib feature
"OMRON receives FDA authorisation for blood pressure monitors with AFib feature" was originally created and published by ...
If I’d put £10,000 into the FTSE 250 5 years ago, here’s how much I’d have now!
The FTSE 250 hasn’t done well over the past five years. But by being selective about which of its stocks to buy, I think it’s ...